-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Aptiv, Lowers Price Target to $53

Benzinga·11/04/2026 16:55:21
Listen to the news
Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $60 to $53.